Hypotensive anaesthesia 5 mark answer
| Agent | Mechanism |
|---|---|
| Volatile anaesthetics (isoflurane, sevoflurane) | Reduce SVR; note - may paradoxically worsen nasal field in FESS by vasodilating nasal microvasculature |
| Sodium nitroprusside (SNP) | Peripheral vasodilator; rapid onset/offset; risk of cyanide toxicity with prolonged use |
| Nitroglycerin | Predominantly venodilator; reduces preload |
| Beta-blockers (esmolol, labetalol) | Reduce HR and cardiac output; preferred in FESS - HR ~60 bpm is the target |
| Calcium channel blockers | Reduce SVR |
| Remifentanil (short-acting opioid) | Used in TIVA protocols; reduces HR and MAP |
| Sympathetic antagonists (ganglionic blockers) | Reduce sympathetic outflow |